Researchers at the URV have used computer techniques to analyse whether 6,466 drugs authorized by various drug agencies for both human and veterinary use could be used to inhibit the M-pro enzyme. The study demonstrates that a human and a veterinary anti-inflammatory drug – Carprofen and Celecoxib – inhibit a key enzyme in the replication and transcription of the virus responsible for COVID-19. The results of the work have been validated by the initiative COVIDMoonshot.
- Custom diets are essential to mental health, new research shows
- Do marketers matter for entrepreneurs?
- A new effect of red ginseng: suppression of lung cancer metastasis
- How are universities planning to tackle emissions associated with food and flying?
- Pressure-regulated excitonic feature enhances photocurrent of all-inorganic 2D perovski